中华核医学与分子影像杂志最新文献

筛选
英文 中文
Application of lung ventilation/perfusion imaging in non-pulmonary embolic diseases 肺通气/灌注成像在非肺栓塞性疾病中的应用
Chinese Journal of Nuclear Medicine and Molecular Imaging Pub Date : 2019-09-25 DOI: 10.3760/CMA.J.ISSN.2095-2848.2019.09.012
Meng Wang, Lei Wang
{"title":"Application of lung ventilation/perfusion imaging in non-pulmonary embolic diseases","authors":"Meng Wang, Lei Wang","doi":"10.3760/CMA.J.ISSN.2095-2848.2019.09.012","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.2095-2848.2019.09.012","url":null,"abstract":"Lung ventilation/perfusion (V/Q) imaging is the recommended diagnostic technique for pulmonary embolism. With the development of imaging equipments, radiopharmaceuticals and new quantitative techniques, lung V/Q imaging has been increasingly used in other lung diseases. This article reviews the clinical application of lung V/Q imaging in non-pulmonary embolic diseases. \u0000 \u0000 \u0000Key words: \u0000Lung disease; Ventilation/perfusion imaging; Trends","PeriodicalId":10099,"journal":{"name":"Chinese Journal of Nuclear Medicine and Molecular Imaging","volume":"39 1","pages":"553-556"},"PeriodicalIF":0.0,"publicationDate":"2019-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45233019","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Multidisciplinary and outpatient clinic experience in the perioperative treatment of Graves hyperthyroidism patients with several complications Graves甲状腺功能亢进症合并多种并发症围手术期治疗的多学科和门诊经验
Chinese Journal of Nuclear Medicine and Molecular Imaging Pub Date : 2019-09-25 DOI: 10.3760/CMA.J.ISSN.2095-2848.2019.09.016
Liang Guan, Yi-Yin Huang, Shuaijun Chen, Xueqin Deng
{"title":"Multidisciplinary and outpatient clinic experience in the perioperative treatment of Graves hyperthyroidism patients with several complications","authors":"Liang Guan, Yi-Yin Huang, Shuaijun Chen, Xueqin Deng","doi":"10.3760/CMA.J.ISSN.2095-2848.2019.09.016","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.2095-2848.2019.09.016","url":null,"abstract":"","PeriodicalId":10099,"journal":{"name":"Chinese Journal of Nuclear Medicine and Molecular Imaging","volume":"39 1","pages":"568-569"},"PeriodicalIF":0.0,"publicationDate":"2019-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44652088","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of short-term deep brain stimulation in subthalamic nucleus on glucose metabolism in Parkinson′s disease 短期丘脑底核脑深部刺激对帕金森病患者糖代谢的影响
Chinese Journal of Nuclear Medicine and Molecular Imaging Pub Date : 2019-09-25 DOI: 10.3760/CMA.J.ISSN.2095-2848.2019.09.001
J. Ge, P. Wu, Y. Guan, Huiwei Zhang, Ling Li, Jiaying Lu, Likun Yang, Wei Lin, C. Zuo
{"title":"Effects of short-term deep brain stimulation in subthalamic nucleus on glucose metabolism in Parkinson′s disease","authors":"J. Ge, P. Wu, Y. Guan, Huiwei Zhang, Ling Li, Jiaying Lu, Likun Yang, Wei Lin, C. Zuo","doi":"10.3760/CMA.J.ISSN.2095-2848.2019.09.001","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.2095-2848.2019.09.001","url":null,"abstract":"Objective \u0000To study the effect of short-term treatment of subthalamic nucleus (STN) deep brain stimulation (DBS) on cerebral glucose metabolism in patients with Parkinson′s disease (PD) and its relationship with the change of brain motor-related nerve pathways. \u0000 \u0000 \u0000Methods \u0000Five patients (2 males, 3 females; age: (63.6±11.8) years) with PD who underwent STN DBS between January 2014 and December 2018 were enrolled in this study. All patients underwent 18F-fluorodeoxyglucose (FDG) PET in \" DBS-off\" state before and 3 months after operation. Quantitative expression of PD-related metabolic pattern (PDRP) were calculated by scaled subprofile model/principal component analysis (SSM/PCA) on PET images. Brain regions with changes of glucose metabolism after DBS were located by statistical parametric mapping (SPM) paired t test. \u0000 \u0000 \u0000Results \u0000Compared with pre-operation, PDRP expression (5.1±1.3 vs 2.9±1.8) and unified Parkinson′s disease rating scale (UPDRS) motor score (50.2±8.2 vs 28.0±5.4) of PD patients were significantly decreased 3 months after STN DBS (t values: 6.17 and 3.88, both P<0.05). After DBS, the glucose metabolism of bilateral globus pallidus/putamen, caudate nucleus, thalamus, insula, pons and cerebellum decreased, while the glucose metabolism of bilateral prefrontal motor area and parietooccipital lobe increased (t=3.75, P<0.01). \u0000 \u0000 \u0000Conclusions \u0000Short-term STN DBS therapy can inhibit the cortico-striatum-pallidum-hypothalamus-cortex motor loop, which is abnormally excitable in the brain of PD. PDRP, as an imaging characterization of the regulation of this loop, is expected to become an imaging marker for monitoring the treatment of PD. \u0000 \u0000 \u0000Key words: \u0000Parkinson disease; Deep brain stimulation; Subthalamic nucleus; Positron-emission tomography; Deoxyglucose","PeriodicalId":10099,"journal":{"name":"Chinese Journal of Nuclear Medicine and Molecular Imaging","volume":"39 1","pages":"513-517"},"PeriodicalIF":0.0,"publicationDate":"2019-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45018191","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Value of 18F-FDG PET/CT in the diagnosis and treatment of colorectal cancer liver metastases 18F-FDG PET/CT在结直肠癌肝转移诊断和治疗中的价值
Chinese Journal of Nuclear Medicine and Molecular Imaging Pub Date : 2019-09-25 DOI: 10.3760/CMA.J.ISSN.2095-2848.2019.09.014
Wu-jian Mao
{"title":"Value of 18F-FDG PET/CT in the diagnosis and treatment of colorectal cancer liver metastases","authors":"Wu-jian Mao","doi":"10.3760/CMA.J.ISSN.2095-2848.2019.09.014","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.2095-2848.2019.09.014","url":null,"abstract":"18F-fluorodeoxyglucose (FDG) PET/CT offers excellent diagnostic performance on colorectal cancer liver metastases(CRCLM) in terms of sensitivity and specificity, and can comprehensively identify the presence of extrahepatic metastases and provide valuable information for the treatment decision making. 18F-FDG PET/CT can also be used in the early assessment of response to CRCLM therapy and survival prediction. However, the diagnostic value of PET/CT is limited for lesions with diameter within 10 mm or with activity inhibited strongly by chemotherapy. PET combined with contrast enhanced CT may have potential value in improving diagnostic sensitivity for CRCLM. \u0000 \u0000 \u0000Key words: \u0000Colorectal neoplasms; Neoplasm metastasis; Liver; Positron-emission tomography; Tomography, X-ray computed; Deoxyglucose","PeriodicalId":10099,"journal":{"name":"Chinese Journal of Nuclear Medicine and Molecular Imaging","volume":"39 1","pages":"560-563"},"PeriodicalIF":0.0,"publicationDate":"2019-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49076623","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diagnostic value and clinical significance of abnormal uptake in extraosseous tissue for differentiating benign from malignant lesions 骨外组织摄取异常对良恶性鉴别诊断价值及临床意义
Chinese Journal of Nuclear Medicine and Molecular Imaging Pub Date : 2019-09-25 DOI: 10.3760/CMA.J.ISSN.2095-2848.2019.09.003
Xia-lian Li, Xinyu Wu, Minmin Tang, Bo Li, Ye Long, Xiaofei Li, Junling Xu
{"title":"Diagnostic value and clinical significance of abnormal uptake in extraosseous tissue for differentiating benign from malignant lesions","authors":"Xia-lian Li, Xinyu Wu, Minmin Tang, Bo Li, Ye Long, Xiaofei Li, Junling Xu","doi":"10.3760/CMA.J.ISSN.2095-2848.2019.09.003","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.2095-2848.2019.09.003","url":null,"abstract":"Objective \u0000To investigate the regularity and clinical significance of abnormal bone uptake of 99Tcm-methylene bisphosphonate (MDP) in benign and malignant lesions. \u0000 \u0000 \u0000Methods \u0000A retrospective analysis was performed on 266 patients (132 males, 134 females, age range: 8-85 years) with abnormal uptake of 99Tcm-MDP in extraosseous tissues from September 2015 to March 2018. The final diagnosis of abnormal uptake was made according to the histopathology, laboratory and related imaging examination (CT, MRI, ultrasound, SPECT/CT or PET/CT imaging) results within 2 weeks after 99Tcm-MDP imaging. Regularity of abnormal 99Tcm-MDP uptake was comprehensively analyzed. Differences between benign and malignant groups were compared by χ2 test or Fisher exact test. \u0000 \u0000 \u0000Results \u0000Abnormal 99Tcm-MDP uptake in extraosseous tissues in 232 patients (87.2%, 232/266) were confirmed as malignant lesions and those in 34 patients (12.8%, 34/266) were benign. There were no significant differences in gender (χ2=0.611, P>0.05), age (P=0.584), and location (P=0.118) between benign and malignant lesions, but the involvement was significantly different (χ2=19.515, P<0.05). There were significant differences between single focus and diffuse foci of single organ, diffuse foci of single organ and multiple foci groups (χ2=8.959, 19.325, both P<0.01). \u0000 \u0000 \u0000Conclusions \u0000The detection rate of malignancy among foci with abnormal 99Tcm-MDP uptake in extraosseous tissues is high, and the malignancy may relate with the involvement of foci. When extraosseous uptake is found, clinical information and related examination results should be comprehensively analyzed and the malignancy should be taken into account. \u0000 \u0000 \u0000Key words: \u0000Skeleton; Neoplasms; Diagnosis, differential; Tomography, emission-computed, single-photon; Tomography, X-ray computed; Technetium Tc 99m medronate","PeriodicalId":10099,"journal":{"name":"Chinese Journal of Nuclear Medicine and Molecular Imaging","volume":"39 1","pages":"522-525"},"PeriodicalIF":0.0,"publicationDate":"2019-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45810786","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Research progress of 18F-Flurpiridaz PET myocardial perfusion imaging 18f -氟吡唑PET心肌灌注显像研究进展
Chinese Journal of Nuclear Medicine and Molecular Imaging Pub Date : 2019-09-25 DOI: 10.3760/CMA.J.ISSN.2095-2848.2019.09.013
Jiao Wang, Jianming Li, Shuai Li
{"title":"Research progress of 18F-Flurpiridaz PET myocardial perfusion imaging","authors":"Jiao Wang, Jianming Li, Shuai Li","doi":"10.3760/CMA.J.ISSN.2095-2848.2019.09.013","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.2095-2848.2019.09.013","url":null,"abstract":"PET myocardial perfusion imaging (MPI) is increasingly used in non-invasive detection and evaluation of coronary artery disease (CAD). However, the wide application of common PET MPI agents (15O-H2O, 13N-NH3·H2O, 82Rb) in clinic is limited by their inherent shortcomings. The development of 18F-Flurpiridaz has opened up a new field of positron blood flow imaging agents. Preliminary results of pre-clinical and clinical trials showed that 18F-Flurpiridaz has important properties (high myocardial uptake, high resolution of perfusion defect, slow myocardial clearance, stable target/non-target ratio, and the ability of quantitative myocardial flow analysis) as an ideal PET MPI agent, so it has a good clinical application prospect. In this paper, the present application and progress of 18F-Flurpiridaz PET MPI are reviewed. \u0000 \u0000 \u0000Key words: \u0000Myocardial perfusion imaging; Positron-emission tomography; Pyridazines; Fluorine radioisotopes; Trends","PeriodicalId":10099,"journal":{"name":"Chinese Journal of Nuclear Medicine and Molecular Imaging","volume":"39 1","pages":"557-559"},"PeriodicalIF":0.0,"publicationDate":"2019-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46062305","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diagnosis of primary osseous malignant tumors with 18F-FDG PET/CT in patients over 40 years old 40岁以上原发性骨恶性肿瘤的18F-FDG PET/CT诊断
Chinese Journal of Nuclear Medicine and Molecular Imaging Pub Date : 2019-09-25 DOI: 10.3760/CMA.J.ISSN.2095-2848.2019.09.002
P. Chen, Wei Chen, Xiaofeng Li
{"title":"Diagnosis of primary osseous malignant tumors with 18F-FDG PET/CT in patients over 40 years old","authors":"P. Chen, Wei Chen, Xiaofeng Li","doi":"10.3760/CMA.J.ISSN.2095-2848.2019.09.002","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.2095-2848.2019.09.002","url":null,"abstract":"Objective \u0000To investigate the value of 18F-fluorodeoxyglucose (FDG) PET/CT in the diagnosis of different pathological types of primary osseous malignant tumors (POMT) in patients over 40 years old. \u0000 \u0000 \u0000Methods \u0000Fifty-two patients (30 males, 22 females, median age: 60(41-81)years) with POMT who underwent 18F-FDG PET/CT and were pathologically confirmed from January 2013 to May 2018 in Cancer Hospital of Tianjin Medical University were reviewed. The region of interest was drawn and the standardized uptake value (SUV) was automatically measured. The SUV in different pathological types of POMT was compared using one-way analysis of variance or two-sample t test. \u0000 \u0000 \u0000Results \u0000The 52 POMT included 22 sarcomas, 16 isolated myelomas (IM), and 14 primary bone lymphomas (PBL). The SUV in PBL was significantly higher that than in sarcomas and IM with the maximum SUV (SUVmax) of 21.6±12.4, 13.5±7.7 and 9.0±6.4 respectively(F=7.56, P<0.01), and the mean SUV (SUVmean) of 12.9±7.8, 7.5±4.5, and 5.6±4.4, respectively(F=6.92, P<0.01). In the sarcoma group, the SUV of undifferentiated sarcomas was significantly higher than that of other well-differentiated sarcomas (SUVmax: 21.1±5.4 vs 11.3±6.9, SUVmean: 11.8±3.3 vs 6.3±4.1; t=-2.92, -2.71, both P<0.01). The growth pattern of sarcomas and IM was different on CT images. \u0000 \u0000 \u0000Conclusions \u0000The FDG uptake of PBL is higher than that of other pathological types. CT features are helpful for the differential diagnosis of POMT in 18F-FDG PET/CT. \u0000 \u0000 \u0000Key words: \u0000Bone neoplasms; Middle aged; Aged; Positron-emission tomography; Tomography, X-ray computed; Deoxyglucose","PeriodicalId":10099,"journal":{"name":"Chinese Journal of Nuclear Medicine and Molecular Imaging","volume":"39 1","pages":"518-521"},"PeriodicalIF":0.0,"publicationDate":"2019-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43993299","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Graves disease after 131I therapy in a case of autonomously functioning thyroid adenoma 自主功能甲状腺腺瘤131I治疗后Graves病1例
Chinese Journal of Nuclear Medicine and Molecular Imaging Pub Date : 2019-09-25 DOI: 10.3760/CMA.J.ISSN.2095-2848.2019.09.010
Na Liu
{"title":"Graves disease after 131I therapy in a case of autonomously functioning thyroid adenoma","authors":"Na Liu","doi":"10.3760/CMA.J.ISSN.2095-2848.2019.09.010","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.2095-2848.2019.09.010","url":null,"abstract":"","PeriodicalId":10099,"journal":{"name":"Chinese Journal of Nuclear Medicine and Molecular Imaging","volume":"39 1","pages":"548-549"},"PeriodicalIF":0.0,"publicationDate":"2019-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46141434","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
18F-FDG PET/CT imaging characteristics of focal peliosis hepatis 局灶性肝泥质病的18F-FDG PET/CT影像学特征
Chinese Journal of Nuclear Medicine and Molecular Imaging Pub Date : 2019-09-25 DOI: 10.3760/CMA.J.ISSN.2095-2848.2019.09.007
Zhijian Liu, T. Geng, Ming-Liang Wang, G. Dong, Hai Geng, M. Zeng
{"title":"18F-FDG PET/CT imaging characteristics of focal peliosis hepatis","authors":"Zhijian Liu, T. Geng, Ming-Liang Wang, G. Dong, Hai Geng, M. Zeng","doi":"10.3760/CMA.J.ISSN.2095-2848.2019.09.007","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.2095-2848.2019.09.007","url":null,"abstract":"","PeriodicalId":10099,"journal":{"name":"Chinese Journal of Nuclear Medicine and Molecular Imaging","volume":"39 1","pages":"542-543"},"PeriodicalIF":0.0,"publicationDate":"2019-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46337947","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Characteristics of 185 thyroid micropapillary carcinoma patients undergoing 131I treatment 185例甲状腺微乳头状癌131I治疗特点分析
Chinese Journal of Nuclear Medicine and Molecular Imaging Pub Date : 2019-09-25 DOI: 10.3760/CMA.J.ISSN.2095-2848.2019.09.005
Y. Long, Cai-xia An
{"title":"Characteristics of 185 thyroid micropapillary carcinoma patients undergoing 131I treatment","authors":"Y. Long, Cai-xia An","doi":"10.3760/CMA.J.ISSN.2095-2848.2019.09.005","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.2095-2848.2019.09.005","url":null,"abstract":"Objective \u0000To compare the clinical features of papillary thyroid microcarcinoma (PTMC) and non-microcarcinoma papillary thyroid carcinoma (PTC). \u0000 \u0000 \u0000Methods \u0000Clinical data of 522 patients (156 males, 366 females, age: 16-77 years) with PTC treated with 131I from January 2014 to September 2018 were analyzed retrospectively. Patients were divided into PTMC group (46 males, 139 females, age: (38.5±6.5) years; tumor diameter≤1.0 cm) and non-microcarcinoma PTC group (110 males, 227 females, age: (40.5±4.5) years; tumor diameter>1.0 cm). General information and TNM status of patients were compared. The t′ test and χ2 test were used to analyze the data. \u0000 \u0000 \u0000Results \u0000Patients was relatively young in PTMC group (t′=2.20, P 0.05; mostly females). The incidence of extraglandular invasion in PTMC group was significantly lower than that in PTC group (33.51%(62/185) vs 56.08%(189/337); χ2=24.37, P 0.05). \u0000 \u0000 \u0000Conclusions \u0000Clinical characteristics of PTC can be influenced by tumor diameter. The features of primary tumor and lymph node metastasis between patients with moderate- and high-risk PTMC and non-microcarcinoma PTC patients are similar, which suggests that 131I therapy is necessary to patients with moderate- and high-risk PTMC. \u0000 \u0000 \u0000Key words: \u0000Thyroid neoplasms; Carcinoma, papillary; Radiotherapy; Iodine radioisotopes","PeriodicalId":10099,"journal":{"name":"Chinese Journal of Nuclear Medicine and Molecular Imaging","volume":"39 1","pages":"532-536"},"PeriodicalIF":0.0,"publicationDate":"2019-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45522616","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信